Bethel, M Angelyn <br/><br/>
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).  [electronic resource] 

 -  Diabetes care  Apr 2017 
 - 494-501 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc16-1135  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Body Mass Index<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Glycated Hemoglobin<br/>Humans<br/>Hypoglycemia--epidemiology<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--epidemiology<br/>Risk Factors<br/>Sitagliptin Phosphate--administration & dosage<br/>Stroke--epidemiology<br/>Treatment Outcome